Jagsonpal Pharmaceuticals Ltd. - Research Center
507789 JAGSNPHARM Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | |
|---|---|---|---|---|---|
| Sales | 47.23 | 57.83 | 60.15 | 55.45 | 60.14 |
| Operating profit | 3.40 | 8.37 | 8.64 | 5.44 | 8.63 |
| Interest | 0.23 | 0.22 | 0.15 | 0.20 | 0.18 |
| Gross profit | 5.69 | 10.42 | 10.48 | 7.80 | 10.20 |
| EPS (Rs) | 1.51 | 2.85 | 2.85 | 2.14 | 2.97 |
Quarterly
results in details
| Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | Dec' 22 | |
|---|---|---|---|---|---|
| Other income | 2.52 | 2.27 | 2.00 | 2.56 | 1.74 |
| Stock adjustment | -0.29 | 1.20 | 1.17 | -1.62 | 1.25 |
| Raw material | 5.88 | 4.91 | 7.53 | 6.32 | 6.12 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 11.64 | 11.70 | 13.70 | 13.21 | 14.20 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 26.61 | 31.65 | 29.12 | 32.10 | 29.94 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.41 | 0.46 | 0.39 | 0.48 | 0.33 |
| Taxation | 1.32 | 2.49 | 2.61 | 1.72 | 2.08 |
| Net profit / loss | 3.96 | 7.47 | 7.48 | 5.60 | 7.78 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 13.14 | 13.10 | 13.10 | 13.10 | 13.10 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 7.19 | 14.47 | 14.36 | 9.81 | 14.36 |
| GPM (%) | 11.44 | 17.33 | 16.87 | 13.45 | 16.48 |
| NPM (%) | 7.97 | 12.43 | 12.03 | 9.66 | 12.58 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis